Previous research has demonstrated that inoculating mice with the dhfr-ts− CC1 strain of L. major confers protective immunity against future infection with virulent L. major strains, confirming its promise as an experimental vaccine for leishmaniasis. This evidence concerns the gene DHFR and leishmaniasis.